Value sales of eye care rose by 4% in 2011. Allergy eye care grew particularly strongly, by 30%, because of reports that the dispersion of pollen would exceed the 2010 level by 200-1,000%. One of the worst pollen dispersion since 2005 caused anxiety among pollen allergic consumers and pushed up sales of allergy eye care. In Japan, more than 20% of the population is said to suffer from pollen allergy and recognised symptoms include runny nose and water eyes. The pollen allergy population is...
Euromonitor International's Eye Care in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Allergy Eye Care, Standard Eye Care.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Eye Care in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Allergy Eye Care, Standard Eye Care.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Eye Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Eye Care by Category: Value 2006-2011
Table 2 Sales of Eye Care by Category: % Value Growth 2006-2011
Table 3 Standard Eye Care by Format: % Value Breakdown 2007-2011
Table 4 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
Table 5 Eye Care Company Shares by Value 2007-2011
Table 6 Eye Care Brand Shares by Value 2008-2011
Table 7 Forecast Sales of Eye Care by Category: Value 2011-2016
Table 8 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016
Daiichi Sankyo Healthcare Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 1 Daiichi Sankyo Healthcare Co Ltd: Key Facts
Summary 2 Daiichi Sankyo Healthcare Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Daiichi Sankyo Healthcare Co Ltd: Competitive Position 2011
Hisamitsu Pharmaceutical Co Inc in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 4 Hisamitsu Pharmaceutical Co Inc: Key Facts
Summary 5 Hisamitsu Pharmaceutical Co Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Hisamitsu Pharmaceutical Co Inc: Competitive Position 2011
Kobayashi Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 7 Kobayashi Pharmaceutical Co Ltd: Key Facts
Summary 8 Kobayashi Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Kobayashi Pharmaceutical Co Ltd: Competitive Position 2011
Rohto Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 10 Rohto Pharmaceutical Co Ltd: Key Facts
Summary 11 Rohto Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 Rohto Pharmaceutical Co Ltd: Competitive Position 2011
Sato Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 13 Sato Pharmaceutical Co Ltd: Key Facts
Summary 14 Sato Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 15 Sato Pharmaceutical Co Ltd: Competitive Position 2011
Taisho Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 16 Taisho Pharmaceutical Co Ltd: Key Facts
Summary 17 Taisho Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 18 Taisho Pharmaceutical Co Ltd: Competitive Position 2011
Takeda Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 19 Takeda Pharmaceutical Co Ltd: Key Facts
Summary 20 Takeda Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 21 Takeda Pharmaceutical Co Ltd: Competitive Position 2011
Executive Summary
High Pollen Levels Push Up Sales of Anti-pollen Positioned Products
March Earthquake Has Limited Impact on Consumer Health Industry
OTC Switch Creates A Major Hit Product - Loxonin S
Collagen Becomes A Beauty Catalyst Among Female Consumers
Competition Poses A Threat To Sales of Tonics and Bottled Nutritive Drinks
Key Trends and Developments
High Pollen Levels in 2011
Rising National Debt and Potential for OTC Switches
Delivery Service by Parapharmacies/drugstores
Electronic Tracking of Customer Medication Usage
Increasing Non-store Retailing Channel Sales
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 10 Life Expectancy at Birth 2006-2011
Market Data
Table 11 Sales of Consumer Health by Category: Value 2006-2011
Table 12 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 13 Consumer Health Company Shares 2007-2011
Table 14 Consumer Health Brand Shares 2008-2011
Table 15 Penetration of Private Label by Category 2006-2011
Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 18 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Consumer Healthcare Registration
Consumer Healthcare Advertising
Consumer Healthcare Packaging
Consumer Healthcare Distribution
Regulation of Japanese Traditional Herbal Remedies (kampo)
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 22 OTC Switches 2009-2011
Definitions
Sources
Summary 23 Research Sources
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Eye Care by Category: Value 2006-2011
Table 2 Sales of Eye Care by Category: % Value Growth 2006-2011
Table 3 Standard Eye Care by Format: % Value Breakdown 2007-2011
Table 4 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
Table 5 Eye Care Company Shares by Value 2007-2011
Table 6 Eye Care Brand Shares by Value 2008-2011
Table 7 Forecast Sales of Eye Care by Category: Value 2011-2016
Table 8 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016
Daiichi Sankyo Healthcare Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 1 Daiichi Sankyo Healthcare Co Ltd: Key Facts
Summary 2 Daiichi Sankyo Healthcare Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Daiichi Sankyo Healthcare Co Ltd: Competitive Position 2011
Hisamitsu Pharmaceutical Co Inc in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 4 Hisamitsu Pharmaceutical Co Inc: Key Facts
Summary 5 Hisamitsu Pharmaceutical Co Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Hisamitsu Pharmaceutical Co Inc: Competitive Position 2011
Kobayashi Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 7 Kobayashi Pharmaceutical Co Ltd: Key Facts
Summary 8 Kobayashi Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Kobayashi Pharmaceutical Co Ltd: Competitive Position 2011
Rohto Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 10 Rohto Pharmaceutical Co Ltd: Key Facts
Summary 11 Rohto Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 Rohto Pharmaceutical Co Ltd: Competitive Position 2011
Sato Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 13 Sato Pharmaceutical Co Ltd: Key Facts
Summary 14 Sato Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 15 Sato Pharmaceutical Co Ltd: Competitive Position 2011
Taisho Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 16 Taisho Pharmaceutical Co Ltd: Key Facts
Summary 17 Taisho Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 18 Taisho Pharmaceutical Co Ltd: Competitive Position 2011
Takeda Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 19 Takeda Pharmaceutical Co Ltd: Key Facts
Summary 20 Takeda Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 21 Takeda Pharmaceutical Co Ltd: Competitive Position 2011
Executive Summary
High Pollen Levels Push Up Sales of Anti-pollen Positioned Products
March Earthquake Has Limited Impact on Consumer Health Industry
OTC Switch Creates A Major Hit Product - Loxonin S
Collagen Becomes A Beauty Catalyst Among Female Consumers
Competition Poses A Threat To Sales of Tonics and Bottled Nutritive Drinks
Key Trends and Developments
High Pollen Levels in 2011
Rising National Debt and Potential for OTC Switches
Delivery Service by Parapharmacies/drugstores
Electronic Tracking of Customer Medication Usage
Increasing Non-store Retailing Channel Sales
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 10 Life Expectancy at Birth 2006-2011
Market Data
Table 11 Sales of Consumer Health by Category: Value 2006-2011
Table 12 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 13 Consumer Health Company Shares 2007-2011
Table 14 Consumer Health Brand Shares 2008-2011
Table 15 Penetration of Private Label by Category 2006-2011
Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 18 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Consumer Healthcare Registration
Consumer Healthcare Advertising
Consumer Healthcare Packaging
Consumer Healthcare Distribution
Regulation of Japanese Traditional Herbal Remedies (kampo)
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 22 OTC Switches 2009-2011
Definitions
Sources
Summary 23 Research Sources
